Belize vs Gabon: Cause of death, by non-communicable diseases, ages 15-59, male
Belize
31.0%
in 2021
Gabon
31.6%
in 2021
Belize rank
168th
Gabon rank
167th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Belize
- Gabon
How they compare
Gabon currently reports 31.6% against 31.0% in Belize, a difference of 0.6%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Belize ahead.
Belize ranks 168th and Gabon ranks 167th of 185 countries.
Across the 3 decades both report, Belize averaged higher in 2 and Gabon in 1.
Head to head by decade
| Decade | Belize | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 35.9% | 28.4% | 7.5% | Belize |
| 2010s | 35.1% | 36.7% | 1.5% | Gabon |
| 2020s | 33.0% | 32.1% | 0.8% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Belize or Gabon?
- Gabon, at 31.6% against 31.0% in Belize as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Belize and Gabon?
- 0.6%, with Gabon ahead.
- How many years of comparable data are there for Belize and Gabon?
- 6 years are reported by both, from 2000 to 2021.
- How do Belize and Gabon rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Belize ranks 168th and Gabon ranks 167th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.